Current Management of Agitation in Alzheimer’s Dementia: What Is Best Practice? is organized by Pri-Med.
Release Date: 06/19/2023
Expiration Date: 06/19/2024
Description:
Agitation is among the most common behavioral symptoms in patients with dementia, including Alzheimer’s dementia. It exacts a significant burden on patients because it is associated with not only greater morbidity and mortality, but also a faster cognitive and functional decline. This activity reviews pharmacological options currently in use—their mechanisms of action, efficacy, and tolerability, as well as relevant guideline recommendations.
Learning Objectives:
• Review drug classes currently in use for the management of agitation associated with dementia due to Alzheimer’s disease
• Review the efficacy and tolerability of currently available pharmacotherapies for agitation associated with dementia due to Alzheimer’s disease